Personalized immune cells tested as new weapon against tough skin cancers
NCT ID NCT07288073
Summary
This study is testing a personalized treatment for people with advanced forms of skin cancer (cutaneous squamous cell carcinoma or Merkel cell carcinoma) that have come back after standard immunotherapy. Doctors take a patient's own immune cells from a tumor, grow large numbers of them in a lab, and then give them back to the patient along with chemotherapy and a drug called Interleukin-2. The main goals are to see if this process is safe and if it can help shrink the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.